Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisCommentary Published on 2020-04-202022-10-29 Journal: World Journal of Emergency Surgery : WJES [Category] Coronavirus, SARS, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) Analysis ARDS ARDS patients base COVID-19 COVID-19 pandemic COVID-19 patient criteria Critical care Critically ill Critically ill patient death defined demonstrated diagnosis of ARDS eligible fibrinolysis IMPROVE Markov Mild moderate Mortality pandemic PaO parameter Patient patient group patients pulmonary failure reduced reducing resource Result social distancing Standard therapy survival syndrome systemic tissue plasminogen activator Tissue plasminogen activator (tPA) transition transitioned USA was reduced [DOI] 10.1186/s13017-020-00305-4 PMC 바로가기 [Article Type] Commentary